NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 72 filers reported holding NEXTCURE INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,090 | -46.5% | 11,697 | -25.3% | 0.00% | – |
| Q2 2023 | $28,195 | +49.6% | 15,664 | +23.0% | 0.00% | – |
| Q1 2023 | $18,851 | +25.8% | 12,737 | +19.8% | 0.00% | – |
| Q4 2022 | $14,985 | -44.5% | 10,628 | +6.5% | 0.00% | – |
| Q3 2022 | $27,000 | -38.6% | 9,977 | +7.0% | 0.00% | – |
| Q2 2022 | $44,000 | -2.2% | 9,327 | +1.8% | 0.00% | – |
| Q1 2022 | $45,000 | +164.7% | 9,160 | +224.6% | 0.00% | – |
| Q4 2021 | $17,000 | – | 2,822 | +6782.9% | 0.00% | – |
| Q3 2021 | $0 | – | 41 | +127.8% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 18 | -99.2% | 0.00% | – |
| Q1 2021 | $21,000 | -75.0% | 2,121 | -72.5% | 0.00% | – |
| Q4 2020 | $84,000 | – | 7,723 | +15043.1% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 51 | -99.4% | 0.00% | – |
| Q1 2020 | $339,000 | +993.5% | 9,153 | +1564.2% | 0.00% | – |
| Q4 2019 | $31,000 | -58.7% | 550 | -77.5% | 0.00% | – |
| Q3 2019 | $75,000 | +240.9% | 2,442 | +69.1% | 0.00% | – |
| Q2 2019 | $22,000 | – | 1,444 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 721,302 | $4,862,000 | 2.75% |
| Sofinnova Investments, Inc. | 2,671,856 | $18,008,000 | 1.07% |
| Canaan Partners X LLC | 321,647 | $2,168,000 | 0.62% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $2,022,000 | 0.42% |
| Diametric Capital, LP | 76,162 | $513,000 | 0.40% |
| Lion Point Capital, LP | 300,000 | $2,022,000 | 0.38% |
| DAFNA Capital Management LLC | 183,491 | $1,237,000 | 0.33% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 217,139 | $1,464,000 | 0.25% |
| Ikarian Capital, LLC | 509,155 | $3,431,000 | 0.24% |
| Orbimed Advisors | 2,711,013 | $18,272,000 | 0.20% |